These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1581221)

  • 1. Unmaintained trilineage response to recombinant human erythropoietin in a patient with myelodysplasia.
    Jones D; Zeigler ZR; Rosenfeld CS; Shadduck RK
    Br J Haematol; 1992 Mar; 80(3):406-7. PubMed ID: 1581221
    [No Abstract]   [Full Text] [Related]  

  • 2. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.
    Bessho M; Toyoda A; Itoh Y; Sakata T; Kawai N; Jinnai I; Saito M; Hirashima K
    Br J Haematol; 1992 Mar; 80(3):409-11. PubMed ID: 1374630
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin for treatment of myelodysplastic syndromes.
    Rafanelli D; Grossi A; Longo G; Vannucchi AM; Bacci P; Ferrini PR
    Leukemia; 1992 Apr; 6(4):323-7. PubMed ID: 1588794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
    Rey C; Bader-Meunier B; Tertian G; Mielot F; Tchernia G; Yver A
    Am J Hematol; 1993 May; 43(1):76-7. PubMed ID: 7686335
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to recombinant human erythropoietin treatment in myelodysplastic syndromes (MDS).
    Hast R; Celsing F; Ekman M; Stenke L
    J Intern Med; 1991 Apr; 229(4):381-2. PubMed ID: 2026993
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable response to recombinant human erythropoietin in a patient with myelodysplastic syndrome.
    Pedrotti C
    Haematologica; 1996; 81(6):591. PubMed ID: 9009449
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
    Stebler C; Tichelli A; Dazzi H; Gratwohl A; Nissen C; Speck B
    Exp Hematol; 1990 Dec; 18(11):1204-8. PubMed ID: 2226680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of circulating erythrocytes from myelodysplastic patients treated with recombinant human erythropoietin.
    Shapiro S; Gershon H; Rosenbaum H; Merchav S
    Leukemia; 1993 Sep; 7(9):1328-33. PubMed ID: 8371583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin in the treatment of myelodysplastic syndromes--response patterns.
    Lewinski UH; Floru S; Cohen AM; Mittelmann M
    Leuk Lymphoma; 1994 Sep; 15(1-2):149-52. PubMed ID: 7858493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant erythropoietin for myelodysplastic syndromes.
    Musto P; Scalzulli PR; Carotenuto M
    Br J Haematol; 1995 Sep; 91(1):256-8. PubMed ID: 7577647
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
    Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
    Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
    Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
    Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
    Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
    Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes.
    Depaoli L; Levis A; Isabella N; Ficara F; Priotto C; Lista P; Foà R; Resegotti L
    Haematologica; 1993; 78(2):118-22. PubMed ID: 8349187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of recombinant erythropoietin in myelodysplasia.
    Mittelman M; Lessin LS
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):993-1009. PubMed ID: 7852220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.
    Niscola P; Tendas A; Giovannini M; Scaramucci L; Cupelli L; Catalano G; Perrotti A; de Fabritiis P
    Support Care Cancer; 2013 Jul; 21(7):1803-5. PubMed ID: 23604522
    [No Abstract]   [Full Text] [Related]  

  • 19. Trilineage response to granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
    Perugini O; Montanari G; Nalli G
    Haematologica; 1995; 80(3):234-7. PubMed ID: 7545637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim report.
    Aloe Spiriti MA; Petti MC; Latagliata R; Avvisati G; De Gregoris C; Proia S; Fazi P; Jaalouk G; Mancini M; Spadea A
    Haematologica; 1993; 78(2):123-6. PubMed ID: 8349188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.